Sotera Health Company (SHC)

NASDAQ

$16.80

-$0.02 (0.15%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$16.67$16.98

Open $16.95

52 Week Range

$9.53$17.78

Previous Close $16.83

Market Cap4.77B

Volume1.25M

Avg Volume2.22M

P/E (TTM)86.13

EPS (TTM)$0.20

Dividend / YieldN/A

Dividend StreakN/A

Analyst Ratings & Targets

Price Target

Consensus Target

$18.50

Based on 4 analysts (last year)

High Target

$20.00

Low Target

$17.00

Current

$16.80

Target

$18.50

$17.00$20.00

Potential upside of 10.09%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$18.67

3 analysts

Last Year

$18.25

4 analysts

All Time

$16.59

17 analysts

Analyst Consensus

Current Consensus

Buy

Based on 12 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

C+

(Score: 2)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows1/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity4/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits4/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Nov 5, 2025	Unknown	Piper Sandler	$17.00	$16.15	+5.26%
Nov 5, 2025	Unknown	Barclays	$20.00	$16.43	+21.73%
Oct 2, 2025	Unknown	Barclays	$19.00	$16.19	+17.36%
May 5, 2025	Matthew Sykes	Goldman Sachs	$17.00	$12.92

Recent Analyst Actions


Nov 5, 2025	Maintained	JP Morgan	Neutral	Neutral
Nov 5, 2025	Maintained	Piper Sandler	Neutral	Neutral
Nov 5, 2025	Maintained	Barclays	Overweight	Overweight
Oct 2, 2025	Maintained	Barclays	Overweight	Overweight
Jun 24, 2025	Maintained	Barclays	Overweight	Overweight

Showing 1 to 5 of 90 entries

Analyst Ratings & Targets

Price Target

Consensus Target

$18.50

Based on 4 analysts (last year)

High Target

$20.00

Low Target

$17.00

Current

$16.80

Target

$18.50

$17.00$20.00

Potential upside of 10.09%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$18.67

3 analysts

Last Year

$18.25

4 analysts

All Time

$16.59

17 analysts

Analyst Consensus

Current Consensus

Buy

Based on 12 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

C+

(Score: 2)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows1/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity4/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits4/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Nov 5, 2025	Unknown	Piper Sandler	$17.00	$16.15	+5.26%
Nov 5, 2025	Unknown	Barclays	$20.00	$16.43	+21.73%
Oct 2, 2025	Unknown	Barclays	$19.00	$16.19	+17.36%
May 5, 2025	Matthew Sykes	Goldman Sachs	$17.00	$12.92

Recent Analyst Actions


Nov 5, 2025	Maintained	JP Morgan	Neutral	Neutral
Nov 5, 2025	Maintained	Piper Sandler	Neutral	Neutral
Nov 5, 2025	Maintained	Barclays	Overweight	Overweight
Oct 2, 2025	Maintained	Barclays	Overweight	Overweight
Jun 24, 2025	Maintained	Barclays	Overweight	Overweight

Showing 1 to 5 of 90 entries